{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:11:13Z","timestamp":1792033873875,"version":"4.4.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"by Sarepta Therapeutics, Inc.","award":["820344-0322-00"],"award-info":[{"award-number":["820344-0322-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glycyl\u2013tRNA synthetase mutations are associated to the Charcot\u2013Marie\u2013Tooth disease type-2D. The GarsP278KY\/+ model for Charcot\u2013Marie\u2013Tooth disease type-2D is known best for its early onset severe neuropathic phenotype with findings including reduced axon size, slow conduction velocities and abnormal neuromuscular junction. Muscle involvement remains largely unexamined. We tested the efficacy of neurotrophin 3 gene transfer therapy in two Gars mutants with severe (GarsP278KY\/+) and milder (Gars\u0394ETAQ\/+) phenotypes via intramuscular injection of adeno-associated virus setoype-1, triple tandem muscle creatine kinase promoter, neurotrophin 3 (AAV1.tMCK.NT-3) at 1 \u00d7 1011 vg dose. In the GarsP278KY\/+ mice, the treatment efficacy was assessed at 12 weeks post-injection using rotarod test, electrophysiology and detailed quantitative histopathological studies of the peripheral nervous system including neuromuscular junction and muscle. Neurotrophin 3 gene transfer therapy in GarsP278KY\/+ mice resulted in significant functional and electrophysiological improvements, supported with increases in myelin thickness and improvements in the denervated status of neuromuscular junctions as well as increases in muscle fibre size along with attenuation of myopathic changes. Improvements in the milder phenotype Gars\u0394ETAQ\/+ was less pronounced. Furthermore, oxidative enzyme histochemistry in muscles from Gars mutants revealed alterations in the content and distribution of oxidative enzymes with increased expression levels of Pgc1a. Cox1, Cox3 and Atp5d transcripts were significantly decreased suggesting that the muscle phenotype might be related to mitochondrial dysfunction. Neurotrophin 3 gene therapy attenuated these abnormalities in the muscle. This study shows that neurotrophin 3 gene transfer therapy has disease modifying effect in a mouse model for Charcot\u2013Marie\u2013Tooth disease type-2D, leading to meaningful improvements in peripheral nerve myelination and neuromuscular junction integrity as well as in a unique myopathic process, associated with mitochondria dysfunction, all in combination contributing to functional outcome. Based on the multiple biological effects of this versatile molecule, we predict neurotrophin 3 has the potential to be beneficial in other aminoacyl-tRNA synthetase-linked Charcot\u2013Marie\u2013Tooth disease subtypes.<\/jats:p>","DOI":"10.1093\/braincomms\/fcab252","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T09:19:51Z","timestamp":1634721591000},"source":"Crossref","is-referenced-by-count":28,"title":["AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in\n                    <i>GarsP278KY\/+<\/i>\n                    mice"],"prefix":"10.1093","volume":"3","author":[{"given":"Burcak","family":"Ozes","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Moss","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Myers","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ridgley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Murrey","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-3943","authenticated-orcid":false,"given":"Zarife","family":"Sahenk","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"},{"name":"Department of Pediatrics and Neurology, Nationwide Children\u2019s Hospital and The Ohio State University, Columbus, OH 43205, USA"},{"name":"Department of Pathology and Laboratory Medicine, Nationwide Children\u2019s Hospital, Columbus, OH 43205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"issue":"5","key":"2021110504382783600_fcab252-B1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/375039","article-title":"Glycyl tRNA synthetase mutations in Charcot\u2013Marie\u2013Tooth disease type 2D and distal spinal muscular atrophy type V","volume":"72","author":"Antonellis","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2021110504382783600_fcab252-B2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1212\/01.wnl.0000201275.18875.ac","article-title":"Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation","volume":"66","author":"Del Bo","year":"2006","journal-title":"Neurology"},{"issue":"1-2","key":"2021110504382783600_fcab252-B3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/NMM:8:1-2:75","article-title":"Autosomal-recessive forms of demyelinating Charcot\u2013Marie\u2013Tooth disease","volume":"8","author":"Dubourg","year":"2006","journal-title":"Neuromolecular Med"},{"issue":"1","key":"2021110504382783600_fcab252-B4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-510X(98)00264-0","article-title":"Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot\u2013Marie\u2013Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15","volume":"161","author":"Sambuughin","year":"1998","journal-title":"J Neurol Sci"},{"issue":"Pt 10","key":"2021110504382783600_fcab252-B5","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awh590","article-title":"Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations","volume":"128","author":"Sivakumar","year":"2005","journal-title":"Brain"},{"issue":"14","key":"2021110504382783600_fcab252-B6","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1074\/jbc.REV118.002955","article-title":"Neurodegenerative Charcot\u2013Marie\u2013Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases","volume":"294","author":"Wei","year":"2019","journal-title":"J Biol Chem"},{"issue":"2","key":"2021110504382783600_fcab252-B7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tins.2009.11.001","article-title":"GARS axonopathy: Not every neuron\u2019s cup of tRNA","volume":"33","author":"Motley","year":"2010","journal-title":"Trends Neurosci"},{"issue":"9","key":"2021110504382783600_fcab252-B8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1212\/01.wnl.0000242619.52335.bc","article-title":"Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene","volume":"67","author":"James","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"2021110504382783600_fcab252-B9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-200472","article-title":"Clinical and genetic features in a series of eight unrelated patients with neuropathy due to glycyl-tRNA synthetase (GARS) variants","volume":"7","author":"Forrester","year":"2020","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"2021110504382783600_fcab252-B10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2014.7184","article-title":"Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies","volume":"312","author":"Taylor","year":"2014","journal-title":"JAMA"},{"key":"2021110504382783600_fcab252-B11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2350-15-36","article-title":"Compound heterozygous mutations in glycyl-tRNA synthetase are a proposed cause of systemic mitochondrial disease","volume":"15","author":"McMillan","year":"2014","journal-title":"BMC Medical Genetics"},{"issue":"6","key":"2021110504382783600_fcab252-B12","doi-asserted-by":"crossref","first-page":"e0178125","DOI":"10.1371\/journal.pone.0178125","article-title":"Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction","volume":"12","author":"Nafisinia","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"2021110504382783600_fcab252-B13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/humu.23287","article-title":"Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation","volume":"38","author":"Oprescu","year":"2017","journal-title":"Hum Mutat"},{"issue":"15","key":"2021110504382783600_fcab252-B14","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1093\/hmg\/ddv176","article-title":"Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology","volume":"24","author":"Grice","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2021110504382783600_fcab252-B15","doi-asserted-by":"crossref","first-page":"e1002399","DOI":"10.1371\/journal.pgen.1002399","article-title":"Charcot\u2013Marie\u2013Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels","volume":"7","author":"Motley","year":"2011","journal-title":"PLoS Genet"},{"key":"2021110504382783600_fcab252-B16","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1038\/ncomms8520","article-title":"Impaired protein translation in Drosophila models for Charcot\u2013Marie\u2013Tooth neuropathy caused by mutant tRNA synthetases","volume":"6","author":"Niehues","year":"2015","journal-title":"Nat Commun"},{"issue":"12","key":"2021110504382783600_fcab252-B17","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/hmg\/ddy127","article-title":"Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neurons","volume":"27","author":"Boczonadi","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2021110504382783600_fcab252-B18","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1523\/JNEUROSCI.19-10-03847.1999","article-title":"Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB","volume":"19","author":"Meier","year":"1999","journal-title":"J Neurosci"},{"issue":"5","key":"2021110504382783600_fcab252-B19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/01.WNL.0000171978.70849.c5","article-title":"NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients","volume":"65","author":"Sahenk","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"2021110504382783600_fcab252-B20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/mt.2013.250","article-title":"AAV1.NT-3 gene therapy for Charcot\u2013Marie\u2013Tooth neuropathy","volume":"22","author":"Sahenk","year":"2014","journal-title":"Mol Ther"},{"issue":"2","key":"2021110504382783600_fcab252-B21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41434-018-0009-8","article-title":"AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse model","volume":"25","author":"Yalvac","year":"2018","journal-title":"Gene Ther"},{"issue":"22","key":"2021110504382783600_fcab252-B22","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther"},{"issue":"5","key":"2021110504382783600_fcab252-B23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.22251","article-title":"Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D","volume":"68","author":"Mendell","year":"2010","journal-title":"Ann Neurol"},{"issue":"12","key":"2021110504382783600_fcab252-B24","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1172\/JCI130600","article-title":"Allele-specific RNA interference prevents neuropathy in Charcot\u2013Marie\u2013Tooth disease type 2D mouse models","volume":"129","author":"Morelli","year":"2019","journal-title":"J Clin Invest"},{"key":"2021110504382783600_fcab252-B25","doi-asserted-by":"crossref","first-page":"146533","DOI":"10.1016\/j.brainres.2019.146533","article-title":"Gene therapy to promote regeneration in Charcot\u2013Marie\u2013Tooth disease","volume":"1727","author":"Sahenk","year":"2020","journal-title":"Brain Res"},{"issue":"7","key":"2021110504382783600_fcab252-B26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism","volume":"27","author":"Handschin","year":"2006","journal-title":"Endocr Rev"},{"issue":"6","key":"2021110504382783600_fcab252-B27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2006.08.027","article-title":"An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot\u2013Marie\u2013Tooth 2D mouse model","volume":"51","author":"Seburn","year":"2006","journal-title":"Neuron"},{"key":"2021110504382783600_fcab252-B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00231-3","article-title":"AAV1.NT-3 gene therapy for X-linked Charcot\u2013Marie\u2013Tooth neuropathy type 1","author":"Ozes","year":"2021","journal-title":"Gene Ther"},{"issue":"5","key":"2021110504382783600_fcab252-B29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00005072-197909000-00007","article-title":"Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy","volume":"38","author":"Sahenk","year":"1979","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"2021110504382783600_fcab252-B30","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/hmg\/ddt659","article-title":"Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot\u2013Marie\u2013Tooth type 2D mice","volume":"23","author":"Sleigh","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"6832","key":"2021110504382783600_fcab252-B31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/35074025","article-title":"Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse","volume":"410","author":"Lin","year":"2001","journal-title":"Nature"},{"issue":"3","key":"2021110504382783600_fcab252-B32","doi-asserted-by":"crossref","first-page":"e93140","DOI":"10.1371\/journal.pone.0093140","article-title":"The role of muscle microRNAs in repairing the neuromuscular junction","volume":"9","author":"Valdez","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2021110504382783600_fcab252-B33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/febs.15024","article-title":"mTORC1-PGC1 axis regulates mitochondrial remodeling during reprogramming","volume":"287","author":"Wang","year":"2020","journal-title":"FEBS J"},{"issue":"1","key":"2021110504382783600_fcab252-B34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1101\/gr.112748.110","article-title":"Copy number variation modifies expression time courses","volume":"21","author":"Chaignat","year":"2011","journal-title":"Genome Res"},{"issue":"8","key":"2021110504382783600_fcab252-B35","doi-asserted-by":"crossref","first-page":"e104896","DOI":"10.1371\/journal.pone.0104896","article-title":"Perinatal protein malnutrition affects mitochondrial function in adult and results in a resistance to high fat diet-induced obesity","volume":"9","author":"Jousse","year":"2014","journal-title":"PLoS One"},{"key":"2021110504382783600_fcab252-B36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mito.2016.05.003","article-title":"Accurate quantification of mouse mitochondrial DNA without co-amplification of nuclear mitochondrial insertion sequences","volume":"29","author":"Malik","year":"2016","journal-title":"Mitochondrion"},{"key":"2021110504382783600_fcab252-B37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-1875-1_3","article-title":"PCR based determination of mitochondrial DNA copy number in multiple species","volume":"1241","author":"Rooney","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2021110504382783600_fcab252-B38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13395-017-0146-6","article-title":"Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis","volume":"7","author":"Yalvac","year":"2017","journal-title":"Skelet Muscle"},{"key":"2021110504382783600_fcab252-B39","doi-asserted-by":"crossref","first-page":"e2248","DOI":"10.21769\/BioProtoc.2248","article-title":"Isolation, culturing, and differentiation of primary myoblasts from skeletal muscle of adult mice","volume":"7","author":"Hindi","year":"2017","journal-title":"Bio Protoc"},{"issue":"7","key":"2021110504382783600_fcab252-B40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/mt.2014.77","article-title":"VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy","volume":"22","author":"Yalvac","year":"2014","journal-title":"Mol Ther"},{"issue":"2","key":"2021110504382783600_fcab252-B41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005072-197703000-00006","article-title":"Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies","volume":"36","author":"Spencer","year":"1977","journal-title":"J Neuropathol Exp Neurol"},{"issue":"22","key":"2021110504382783600_fcab252-B42","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1073\/pnas.82.22.7716","article-title":"Experimental diabetic neuropathy: Impairment of slow transport with changes in axon cross-sectional area","volume":"82","author":"Medori","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2021110504382783600_fcab252-B43","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1523\/JNEUROSCI.1762-15.2016","article-title":"Synaptic deficits at neuromuscular junctions in two mouse models of Charcot\u2013Marie\u2013Tooth type 2d","volume":"36","author":"Spaulding","year":"2016","journal-title":"J Neurosci"},{"key":"2021110504382783600_fcab252-B44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4020-6768-6_10","volume-title":"Skeletal muscle repair and regeneration","author":"Karpati","year":"2008"},{"issue":"11","key":"2021110504382783600_fcab252-B45","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/hmg\/ddp121","article-title":"Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy","volume":"18","author":"Chiu","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2021110504382783600_fcab252-B46","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/hmg\/ddw063","article-title":"Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy","volume":"25","author":"Griffin","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2021110504382783600_fcab252-B47","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41419-020-02798-y","article-title":"Developmental demands contribute to early neuromuscular degeneration in CMT2D mice","volume":"11","author":"Sleigh","year":"2020","journal-title":"Cell Death Dis"},{"issue":"2","key":"2021110504382783600_fcab252-B48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00334502","article-title":"Distal terminal axonopathy produced by 2,4-dithiobiuret: Effects of long-term intoxication in rats","volume":"81","author":"Sahenk","year":"1990","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2021110504382783600_fcab252-B49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(80)90980-4","article-title":"Axoplasmic transport in zinc pyridinethione neuropathy: Evidence for an abnormality in distal turn-around","volume":"186","author":"Sahenk","year":"1980","journal-title":"Brain Res"},{"issue":"5","key":"2021110504382783600_fcab252-B50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF01355533","article-title":"Weak-base amines inhibit the anterograde-to-retrograde conversion of axonally transported vesicles in nerve terminals","volume":"20","author":"Sahenk","year":"1991","journal-title":"J Neurocytol"},{"issue":"16","key":"2021110504382783600_fcab252-B51","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/glia.20888","article-title":"Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes","volume":"57","author":"Coelho","year":"2009","journal-title":"Glia"},{"issue":"21","key":"2021110504382783600_fcab252-B52","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1523\/JNEUROSCI.0232-09.2009","article-title":"Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination","volume":"29","author":"Narayanan","year":"2009","journal-title":"J Neurosci"},{"issue":"19","key":"2021110504382783600_fcab252-B53","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0234-09.2009","article-title":"Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation","volume":"29","author":"Tyler","year":"2009","journal-title":"J Neurosci"},{"issue":"5","key":"2021110504382783600_fcab252-B54","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1523\/JNEUROSCI.4814-11.2012","article-title":"Arrest of myelination and reduced axon growth when Schwann cells lack mTOR","volume":"32","author":"Sherman","year":"2012","journal-title":"J Neurosci"},{"issue":"10","key":"2021110504382783600_fcab252-B55","doi-asserted-by":"crossref","first-page":"e01118","DOI":"10.1002\/brb3.1118","article-title":"Efficacy of exogenous pyruvate in Trembler(J) mouse model of Charcot\u2013Marie\u2013Tooth neuropathy","volume":"8","author":"Sahenk","year":"2018","journal-title":"Brain Behav"},{"issue":"4","key":"2021110504382783600_fcab252-B56","first-page":"167","article-title":"Nerve growth factor and neurotrophin-3 affect functional recovery following peripheral nerve injury differently","volume":"18","author":"Young","year":"2001","journal-title":"Restor Neurol Neurosci"},{"issue":"7 Pt 1","key":"2021110504382783600_fcab252-B57","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1523\/JNEUROSCI.15-07-04796.1995","article-title":"Neurotrophins promote maturation of developing neuromuscular synapses","volume":"15","author":"Wang","year":"1995","journal-title":"J Neurosci"},{"issue":"6427","key":"2021110504382783600_fcab252-B58","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/363350a0","article-title":"Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF","volume":"363","author":"Lohof","year":"1993","journal-title":"Nature"},{"issue":"1","key":"2021110504382783600_fcab252-B59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jnr.490420104","article-title":"Expression of neurotrophins in skeletal muscle: Quantitative comparison and significance for motoneuron survival and maintenance of function","volume":"42","author":"Griesbeck","year":"1995","journal-title":"J Neurosci Res"},{"issue":"1","key":"2021110504382783600_fcab252-B60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1460-9568.2009.07032.x","article-title":"Investigation of neuromuscular abnormalities in neurotrophin-3-deficient mice","volume":"31","author":"Sheard","year":"2010","journal-title":"Eur J Neurosci"},{"issue":"3","key":"2021110504382783600_fcab252-B61","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI131989","article-title":"Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models","volume":"130","author":"Kim","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"2021110504382783600_fcab252-B62","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.152.5.1107","article-title":"Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy","volume":"152","author":"Cifuentes-Diaz","year":"2001","journal-title":"J Cell Biol"},{"issue":"6","key":"2021110504382783600_fcab252-B63","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/NEN.0b013e31821cbd8b","article-title":"Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy","volume":"70","author":"Dachs","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"30","key":"2021110504382783600_fcab252-B64","doi-asserted-by":"crossref","first-page":"12307","DOI":"10.1073\/pnas.1104293108","article-title":"Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening","volume":"108","author":"He","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2021110504382783600_fcab252-B65","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41467-018-03461-z","article-title":"Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot\u2013Marie\u2013Tooth neuropathy","volume":"9","author":"Mo","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"2021110504382783600_fcab252-B66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/brain\/awx375","article-title":"HDAC6 is a therapeutic target in mutant GARS-induced Charcot\u2013Marie\u2013Tooth disease","volume":"141","author":"Benoy","year":"2018","journal-title":"Brain"},{"issue":"7575","key":"2021110504382783600_fcab252-B67","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nature15510","article-title":"CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase","volume":"526","author":"He","year":"2015","journal-title":"Nature"},{"key":"2021110504382783600_fcab252-B68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnmol.2018.00055","article-title":"Plexin-semaphorin signaling modifies neuromuscular defects in a Drosophila model of peripheral neuropathy","volume":"11","author":"Grice","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2021110504382783600_fcab252-B69","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1038\/s41598-017-10005-w","article-title":"Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis","volume":"7","author":"Sleigh","year":"2017","journal-title":"Sci Rep"},{"issue":"16","key":"2021110504382783600_fcab252-B70","doi-asserted-by":"crossref","first-page":"E3324","DOI":"10.1073\/pnas.1614557114","article-title":"Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations","volume":"114","author":"Sleigh","year":"2017","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcab252\/40830816\/fcab252.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/4\/fcab252\/41077164\/fcab252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/4\/fcab252\/41077164\/fcab252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:39:22Z","timestamp":1636072762000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcab252\/6409185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcab252","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741128990.793594348","asserted-by":"object"}]},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,10,1]]},"article-number":"fcab252"}}